Metalyse 5 000 units (25 mg) powder for solution for injection
1123-0060
Phase 3 small_molecule active
Quick answer
Metalyse 5 000 units (25 mg) powder for solution for injection for Acute Ischemic Stroke is a Phase 3 program (small_molecule) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- Acute Ischemic Stroke
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active